Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  1. Virus-specific antibody indices may supplement the total IgG index in diagnostics of multiple sclerosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Antibodies to Epstein-Barr virus and neurotropic viruses in multiple sclerosis and optic neuritis

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  3. MAIT cell subtypes in multiple sclerosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  4. Expression of melanoma cell adhesion molecule-1 (MCAM-1) in natalizumab-treated multiple sclerosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  1. All anti-CD20 monoclonal antibodies have similar efficacy and risks: No

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Peripheral helper T cells in the pathogenesis of multiple sclerosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  3. Time to first treatment and risk of disability pension in relapsing-remitting multiple sclerosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

Vis graf over relationer

Perfluorinated alkylated substances (PFASs) have immunomodulatory effects but the impact on multiple sclerosis (MS) and cellular immune functions is only sparsely described. In the present study, we found lower concentrations of the long chain PFAS perfluorooctane sulfonic acid (PFOS) in MS than in healthy controls (HC). In HC, we did not detect associations between PFOS concentrations and immune phenotypes. Analyzing the impact of known MS risk factors on cellular immune functions, we found that smoking and Epstein-Barr nuclear antigen 1 antibodies were associated with distinct circulating immune cell changes. In summary, current background PFAS exposure is not an important risk factor for MS.

OriginalsprogEngelsk
TidsskriftJournal of Neuroimmunology
Vol/bind330
Sider (fra-til)90-95
Antal sider6
ISSN0165-5728
DOI
StatusUdgivet - 15 maj 2019

Bibliografisk note

Copyright © 2019 Elsevier B.V. All rights reserved.

ID: 58576743